ADO
Director Trades
| Date | Director | Value |
|---|---|---|
| E. Crouch | $8,875 | |
| D. Radford | $10,356 | |
| G. Cumming | $20,000 | |
| G. McLoughlin | $2,375 | |
| K. Woodthorpe | $1,600 |
Company News
AnteoTech receives first commercial order for Ultranode silicon battery from European EV maker
Queensland-based chemistry company AnteoTech (ASX: ADO) has received a $40,000 commercial order for its proprietary Ultranode 70%-silicon battery anode technology. The maiden sale came from a European electric vehicle manufacturer (known as EV1) that has been trialling the product to assess its performance-enhancing characteristics. The ongoing trial will be carried out in parallel with EV1’s […]
AnteoTech unveils rapid and more accurate proof of concept COVID-19 test
Surface chemistry company AnteoTech (ASX: ADO) emerged from a trading halt this morning to announce a potential breakthrough in the struggle against COVID-19. The company revealed it has developed a proof of concept COVID-19 and flu multiplex test platform that can detect whether patients have been, or are currently, infected with the coronavirus. The dual […]
AnteoTech signs agreement with Merck to co-develop products for global point-of-care market
Queensland-based chemistry company AnteoTech (ASX: ADO) has signed a non-binding heads of agreement with German pharmaceutical and life sciences company Merck KGaA to co-develop products for the world’s rapidly-growing point of care diagnostic testing market. The products will harness Merck’s full range of europium particles activated with AnteoBind to offer an advanced toolset for assay […]
AnteoTech partners with US company to develop point-of-care products using AnteoBind coatings
Chemistry and coating company AnteoTech (ASX: ADO) has signed a commercial agreement with IMRA America Inc for the joint development of AnteoBind-coated gold particles to be used in point-of-care diagnostics. Under the agreement, AnteoTech (formerly known as Anteo Diagnostics) will activate IMRA’s i-colloid gold particles with AnteoBind. The combined product will be branded and marketed […]
Anteo Diagnostics joins forces with Canadian company to enhance lateral flow tests
Australian nanotechnology company Anteo Diagnostics (ASX: ADO) has announced a collaboration with Canada’s Sona Nanotech Inc to help speed the development and improve the performance of lateral flow immunoassays. Also known as lateral flow tests, lateral flow immunoassays are paper-based devices intended to detect the presence or absence of targets in a liquid sample without […]
Anteo Diagnostics looks to expand market footprint in Chinese in-vitro market
Chemistry company Anteo Diagnostics (ASX: ADO) has asserted that it has found “an ideal partner” to distribute its AnteoBind Conjugation Kits throughout China. Earlier today, Anteo said it had signed a distribution agreement with Chinese company Shanghai GeneoDx Biotechnology, a diagnostic product and distribution company, currently affiliated to China National Pharmaceutical Group (SINOPHARM), a Chinese state-owned […]
Anteo Diagnostics teams up with global battery materials supplier
Lithium-ion battery technology developer Anteo Diagnostics (ASX: ADO) has teamed up with a European-based battery material supplier to advance its nano-coating technology in lithium-ion batteries. Anteo Diagnostics has created a nano-coating called AnteoCoat for silicon giving it qualities required for incorporation in the lithium-ion anode – potentially replacing graphite which is currently used. Silicon can […]
Anteo Diagnostics clinches confidentiality agreement with major battery end-user for AnteoCoat
Disruptive technology developer Anteo Diagnostics (ASX: ADO) has clinched a confidentiality agreement with an undisclosed major battery end-user regarding its AnteoCoat product. The confidentiality agreement was secured at the recent Japan Battery conference after Anteo carried out in-depth discussions with multiple end-users and battery material manufacturers. AnteoCoat is based on nano-coating technology and the coating […]
Anteo Diagnostics to test potentially disruptive nano-coating technology in lithium-ion battery
Anteo Diagnostics (ASX: ADO) has dipped into lithium-ion battery waters after securing an agreement with US-based battery consulting company Polaris Battery Labs to test Anteo’s nano-coating technology on silicon within lithium-ion batteries, which if successful, could disrupt the entire industry. The duo will test the AnteoCoat product in various concentrations on silicon incorporated into the […]
Company Videos
No videos found.